ADCT
ADCT
CH0499880968
ADC Therapeutics SA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
220.87M EUR
136.36M EUR
476.87M EUR
443.89M EUR
Enterprise Value
422.08M EUR
34.81M EUR
362.53M EUR
299.58M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.16x
--
--
--
Price to Sales
2.78x
1.71x
6.02x
7.61x
Price to Book
--
--
--
--
EV/Revenue
5.3x
0.44x
4.58x
5.14x
EV/EBITDA
-4.5x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-30.84%
-75.02%
-24.03%
-19.11%
ende